Wissenschaftliche Arbeiten

Doç. Dr. Zeynep Yegin Katran

60 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Use of omalizumab in chemotherapy rapid drug desensitization: Can anaphylaxis be prevented?

    Allergy, 2023

    Quelle: ORCID

  2. Successful Treatment of Tuberculosis Combined With Rifampicin Induced Interstitial Nephritis: A Case Report

    International Journal of Nephrology and Kidney Failure, 2023

    DOI 10.16966/2380-5498.235 Frei zugänglicher VolltextQuelle: OpenAlex

  3. Dahili Hastalarda Özel Beslenme ve Diyet Yönetimi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.2182 Quelle: OpenAlex

  4. Management of type 1 hypersensitivity reactions to antituberculosis drug: Succesful Desensitization

    Research Square, 2022

    DOI 10.21203/rs.3.rs-1752643/v1 Frei zugänglicher VolltextQuelle: ORCID

  5. Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

    Allergy Asthma and Clinical Immunology, 2022

    DOI 10.1186/s13223-022-00737-4 PMID 36414980 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  6. Successful Oxaliplatin Desensitization After Omalizumab Administration

    Research Square, 2022

    DOI 10.21203/rs.3.rs-2313500/v1 Frei zugänglicher VolltextQuelle: ORCID

  7. Treatment and Management of Hypersensitivity Reactions Developed Against Anti-Tuberculosis Drug

    International Journal of Mycobacteriology, 2022

    DOI 10.4103/ijmy.ijmy_78_22 PMID 36260451 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  8. Tuberculosis Treatment-related Lichenoid Drug Eruptions

    International Journal of Mycobacteriology, 2022

    DOI 10.4103/ijmy.ijmy_151_22 PMID 36510939 Frei zugänglicher VolltextQuelle: ORCID

  9. The predictive value of qSOFA and CURB-65 scores in predicting the hospitalization need and mortality in patients with acute exacerbation of chronic obstructive pulmonary disease

    Italian Journal of Emergency Medicine, 2021

    DOI 10.23736/s2532-1285.20.00039-7 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  10. Follow-up of 1887 patients receiving tumor necrosis-alpha antagonists: Tuberculin skin test conversion and tuberculosis risk

    The Clinical Respiratory Journal, 2018

    DOI 10.1111/crj.12726 PMID 29028148 17 Zitationen (Europe PMC) Quelle: ORCID